Companies: 10,795·Total market cap: $144.5T
Johnson & Johnson

Johnson & Johnson

JNJNYSEHealthcare● Active
$232.77
+$4.60(+2.02%)
Market Cap$560.3B
P/E Ratio
52W High$251.71
52W Low$149.04
Overview

Johnson & Johnson (JNJ) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

JNJ · net income · updated Jun 8, 2026

Core profitability metrics

Net income was $26.80B for FY2025 (fiscal year ending 2025-12-28), up 90.6% year-over-year. Net profit margin was 28.5%. Based on available data, Johnson & Johnson has been profitable since at least 2011.

FY2025 Net Income$26.80B▲ +90.6% YoY
Trailing 12M (TTM)$21.04Btrailing 4 quarters sum
Net Profit Margin28.5%$26.80B ÷ $94.19B
YoY Change+90.6%
5-Year CAGR+12.7%FY2020 → FY2025
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · JNJ net income history · JNJ profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025$26.80B▲ +90.6%28.5%
FY2024$14.07B▼ 60.0%15.8%
FY2023$35.15B▲ +95.9%41.3%
FY2023$17.94B▼ 14.1%22.4%
FY2022$20.88B▲ +41.9%26.5%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
Johnson & Johnson
Johnson & JohnsonYOU
JNJ
$26.80B+90.6%
#2
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%
#3
Merck & Co., Inc.
Merck & Co., Inc.
MRK
$18.25B+6.6%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%
#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Johnson & Johnson (JNJ) reported net income of $26.80B for FY2025 (fiscal year ending 2025-12-28), up 90.6% year-over-year. The net profit margin was 28.5% — meaning the company kept $0.28 of every dollar of revenue as profit.

Based on available data, Johnson & Johnson has been profitable since at least 2011. Net income reached a peak of $35.15B in FY2023. Data available for 15 fiscal years.

Johnson & Johnson's net profit margin was 28.5% for FY2025, based on the latest annual results.

Investors sometimes search for "Johnson & Johnson net worth" — the company's market capitalization is a separate figure from JNJ net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

JNJ net income · 5 questions

Johnson & Johnson is profitable. The company reported net income of $26.80B for FY2025, a net profit margin of 28.5%. Net income was up 90.6% year-over-year. Based on available data, Johnson & Johnson has been profitable since at least 2011.

is JNJ profitabledoes JNJ make a profitJNJ profitabilityJNJ profitable company

Source: FMP /income-statement · GAAP · Johnson & Johnson · Johnson & Johnson SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026